Clinical Trials Browser

Phase 2 × Interventional × Diabetes Mellitus × Clear all

NCT07557914 2026-04-30

Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes - A Multicenter, Prospective, Single-arm Clinical Study

Phase 2 Not yet recruiting

Gastrointestinal

Diabetes Mellitus, Carcinoma, Hepatocellular

NCT05306028 2025-02-21

Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c)

Phase 2 Active not recruiting

Diabetes Mellitus, Insulin Resistance

NCT02819011 2020-02-27

OHI--Randomized Control Trial to Evaluate Efficacy, Acceptability, and Perception of Benefit of an Innovative Custom AFO

Phase 2 Completed

44 enrolled 16 charts

Frailty, Arthritis, Diabetes Mellitus, Neoplasms, Parkinson Disease, Peripheral Arterial Disease

NCT04001725 2019-11-13

OPTIMAL

Phase 2 Unknown

BreastCNSDermatologicThoracic

Brain Neoplasms, Breast Neoplasms, Diabetes Mellitus, Lung Neoplasms, Melanoma, Neoplasms

NCT02001051 2018-06-14

Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism

Phase 2 Terminated

4 enrolled 10 charts

Adrenal incidentaloma, Adrenal Gland Neoplasms, Cushing Syndrome, Diabetes Mellitus, Hypercholesterolemia, Hypertension, Obesity, Osteoporosis